DFT Calculations and In silico Study of Chlorogenic, Ellagic and Quisqualic acids as Potential Inhibitors of SARS-CoV-2 Main Protease Mpro

被引:6
|
作者
Shahab, Siyamak [1 ,2 ,3 ]
Kaviani, Sadegh [4 ]
Sheikhi, Masoome [5 ]
Almodarresiyeh, Hora Alhosseini [6 ]
Al Saud, Sultan [1 ,3 ]
机构
[1] Belarusian State Univ, ISEI BSU, Minsk, BELARUS
[2] Natl Acad Sci Belarus, Inst Phys Organ Chem, 13 Surganov Str, Minsk 220072, BELARUS
[3] Natl Acad Sci Belarus, Inst Chem New Mat, 36 Skarina Str, Minsk 220141, BELARUS
[4] Ferdowsi Univ Mashhad, Fac Sci, Dept Chem, Mashhad, Razavi Khorasan, Iran
[5] Islamic Azad Univ, Gorgan Branch, Young Researchers & Elite Club, Gorgan, Golestan, Iran
[6] Meybod Univ, Sch Engn, Dept Mat Sci & Engn, Meybod 8961699557, Yazd, Iran
来源
BIOINTERFACE RESEARCH IN APPLIED CHEMISTRY | 2022年 / 12卷 / 01期
关键词
SARS-CoV-2 main protease M-pro; DFT; molecular docking; chlorogenic; Ellagic and Quisqualic acids; pharmacokinetic properties; COFFEE; METABOLITES; DERIVATIVES; DISCOVERY; TRANSPORT; UV/VIS; HUMANS;
D O I
10.33263/BRIAC121.061073
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
In the present work, at first, density functional theory calculations were performed to investigate the molecular structure of the Chlorogenic, Ellagic, and Quisqualic acids by CAM-B3LYP/MidiX level of theory. A detail of quantum molecular descriptors of the title compounds such as ionization potential (IP) and Electron Affinities (EA), Hardness (eta), Softness (S), Electronegativity (mu), Electrophilic Index (omega), Electron Donating Power (omega-), Electron Accepting Power (omega+) and Energy Gap (Eg) have been calculated. Pharmacokinetic properties of the title compounds and their bioactivity were investigated. In the following, a molecular docking study was carried out to screen for an effective available compound that may work as a strong inhibitor for the SARS-CoV-2 main protease Mpro. The binding energy between SARS-CoV-2 main protease Mpro and title organic acids showed a good binding affinity. Therefore, the Chlorogenic, Ellagic, and Quisqualic acids can be used for potential application against the SARS-CoV-2 main protease Mpro.
引用
收藏
页码:61 / 73
页数:13
相关论文
共 50 条
  • [21] In silico studies on stilbenolignan analogues as SARS-CoV-2 Mpro inhibitors
    Cetin, Adnan
    CHEMICAL PHYSICS LETTERS, 2021, 771
  • [22] Novel Cephalosporins Against the Main Protease of SARS CoV (Mpro O, Mpro WT): Molecular Docking and DFT Study
    Mubarik, Adeel
    Khan, Muhammad Asim
    Mutahir, Sadaf
    Almehizia, Abdulrahman A.
    Ju, Xue-Hai
    CHEMISTRYSELECT, 2024, 9 (45):
  • [23] Triamcinolone as a Potential Inhibitor of SARS-CoV-2 Main Protease and Cytokine Storm: An In silico Study
    Mishra, Amaresh
    Qais, Faizan Abul
    Pathak, Yamini
    Camps, Ihosvany
    Tripathi, Vishwas
    LETTERS IN DRUG DESIGN & DISCOVERY, 2023, 20 (09) : 1230 - 1242
  • [24] Computational Repurposing of Potential Dimerization Inhibitors against SARS-CoV-2 Main Protease
    Borkotoky, Subhomoi
    Prakash, Archisha
    Modi, Gyan Prakash
    Dubey, Vikash Kumar
    LETTERS IN DRUG DESIGN & DISCOVERY, 2024, 21 (04) : 799 - 808
  • [25] Computational investigations of three main drugs and their comparison with synthesized compounds as potent inhibitors of SARS-CoV-2 main protease (Mpro): DFT, QSAR, molecular docking, and in silico toxicity analysis
    Mohapatra, Ranjan K.
    Perekhoda, Lina
    Azam, Mohammad
    Suleiman, Marharyta
    Sarangi, Ashish K.
    Semenets, Anton
    Pintilie, Lucia
    Al-Resayes, Saud, I
    JOURNAL OF KING SAUD UNIVERSITY SCIENCE, 2021, 33 (02)
  • [26] Allosteric inhibitors of the main protease of SARS-CoV-2
    Samrat, Subodh Kumar
    Xu, Jimin
    Xie, Xuping
    Gianti, Eleonora
    Chen, Haiying
    Zou, Jing
    Pattis, Jason G.
    Elokely, Khaled
    Lee, Hyun
    Li, Zhong
    Klein, Michael L.
    Shi, Pei-Yong
    Zhou, Jia
    Li, Hongmin
    ANTIVIRAL RESEARCH, 2022, 205
  • [27] Hemi-Babim and Fenoterol as Potential Inhibitors of MPro and Papain-like Protease against SARS-CoV-2: An In-Silico Study
    Alzamami, Ahmad
    Alturki, Norah A.
    Alghamdi, Youssef Saeed
    Ahmad, Shaban
    Alshamrani, Saleh
    Asiri, Saeed A.
    Mashraqi, Mutaib M.
    MEDICINA-LITHUANIA, 2022, 58 (04):
  • [28] In Silico Substrate-Binding Profiling for SARS-CoV-2 Main Protease (Mpro) Using Hexapeptide Substrates
    Zabo, Sophakama
    Lobb, Kevin Alan
    VIRUSES-BASEL, 2023, 15 (07):
  • [29] Potential SARS-CoV-2 protease Mpro inhibitors: repurposing FDA-approved drugs
    Kouznetsova, Valentina L.
    Huang, David Z.
    Tsigelny, Igor F.
    PHYSICAL BIOLOGY, 2021, 18 (02)
  • [30] Naturally occurring anthraquinones as potential inhibitors of SARS-CoV-2 main protease: an integrated computational study
    Das, Sourav
    Singh, Anirudh
    Samanta, Sintu Kumar
    Roy, Atanu Singha
    BIOLOGIA, 2022, 77 (04) : 1121 - 1134